Paolo Tarantino: Thanks to The ASCO Post for featuring my ADC talk at IBC East

Paolo Tarantino shared a post by The ASCO Post, on X, adding:

”Thanks to The ASCO Post for featuring my ADC talk at IBC East. Major efforts are ongoing to navigate the next generation of ADCs. Innovative constructs, novel biomarkers and insights on mechanisms of resistance will guide a new era in cancer treatment. Soon.”

Quoting The ASCO Post‘s post:

”Paolo Tarantino on the Current and Future Landscape of Antibody-Drug Conjugates.”

Source: Paolo Tarantino/X and The ASCO Post/X

Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a  publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.